Literature DB >> 16769982

Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience.

Markus Raderer1, Stefan Wöhrer, Berthold Streubel, Marlene Troch, Karl Turetschek, Ulrich Jäger, Cathrin Skrabs, Alexander Gaiger, Johannes Drach, Andreas Puespoek, Michael Formanek, Martha Hoffmann, Wolfgang Hauff, Andreas Chott.   

Abstract

PURPOSE: Molecular data and preliminary clinical findings have suggested mucosa-associated lymphoid tissue (MALT) lymphoma as a multifocal disease in a high percentage of patients. We report our findings with an extensive staging routine applied in patients diagnosed with MALT lymphoma at our institution. PATIENTS AND METHODS: A total of 140 consecutive patients (61 with gastric and 79 with extragastric MALT lymphoma) underwent staging according to a standardized protocol. Staging included gastroscopy with multiple biopsies, endosonography of the upper GI tract, computed tomography of thorax and abdomen, lymph node sonography, colonoscopy with multiple biopsies, otorhinolaryngologic assessment, magnetic resonance imaging of salivary and lacrimal glands, and bone marrow biopsy. All lesions suggestive of lymphoma involvement were subjected to biopsy, if accessible, and biopsies were evaluated for MALT lymphoma-specific genetic aberrations by means of reverse transcriptase polymerase chain reaction and/or fluorescent in situ hybridization.
RESULTS: Fifteen (25%) of 61 patients with gastric MALT lymphoma had multiorgan involvement, with dissemination beyond the GI tract in six patients. By contrast, significantly more patients with extragastric MALT lymphoma had dissemination to another MALT organ (37 of 79 patients, 46%; P = .045). Nine of these 37 patients had dissemination to the stomach. Only three (2%) of 140 patients had bone marrow involvement. Multifocality was significantly associated with t(11;18)(q21;q21) in gastric lymphomas (P = .045) and with trisomy 18 in extragastric lymphomas (P = .011).
CONCLUSION: Our findings suggest that MALT lymphoma frequently presents as a multifocal disease. Extragastric MALT lymphomas are significantly more prone to dissemination than gastric MALT lymphomas.

Entities:  

Mesh:

Year:  2006        PMID: 16769982     DOI: 10.1200/JCO.2006.06.0723

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  31 in total

1.  [Follicular and mantle cell lymphoma. Extranodal involvement of primarily nodal indolent B-cell lymphomas].

Authors:  W Klapper; H H Wacker
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

2.  Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma.

Authors:  Constanze Jonak; Marlene Troch; Barbara Kiesewetter; Julius Lukas; Leonhard Müllauer; Ulrich Jäger; Andreas Chott; Markus Raderer
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 3.  Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Marlene Troch; Barbara Kiesewetter; Markus Raderer
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

4.  Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study.

Authors:  Sung Yong Oh; Won Seog Kim; Jin Seok Kim; Seok Jin Kim; Suee Lee; Dae Ho Lee; Jong-Ho Won; In Gyu Hwang; Min Kyoung Kim; Soon Il Lee; Yee Soo Chae; Deok-Hwan Yang; Hye Jin Kang; Chul Won Choi; Jinny Park; Hyo Jung Kim; Jung Hye Kwon; Ho Sup Lee; Gyeong-Won Lee; Hyeon Seok Eom; Jae-Yong Kwak; Won Sik Lee; Cheolwon Suh; Hyo-Jin Kim
Journal:  Int J Hematol       Date:  2010-09-14       Impact factor: 2.490

5.  Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma.

Authors:  Shunan Qi; May Y Huang; Yong Yang; Heiko Schöder; Sewit Teckie; Ariela Noy; Karen Chau; Joachim Yahalom
Journal:  Blood Adv       Date:  2018-03-27

6.  Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.

Authors:  Soley Bayraktar; Ulas D Bayraktar; Alexandra Stefanovic; Izidore S Lossos
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

7.  [Clarithromycin therapy of a B cell MALT lymphoma].

Authors:  L Danilko; K Haas; U Schönherr; G Tschurtschenthaler
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

8.  Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.

Authors:  Monika Joshi; Hassan Sheikh; Kamal Abbi; Sarah Long; Kamal Sharma; Mark Tulchinsky; Elliot Epner
Journal:  Ther Adv Hematol       Date:  2012-10

9.  Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

Authors:  Marlene Troch; Barbara Kiesewetter; Wolfgang Willenbacher; Ella Willenbacher; Armin Zebisch; Werner Linkesch; Michael Fridrik; Leonhard Müllauer; Richard Greil; Markus Raderer
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

10.  Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.

Authors:  Susann Stollberg; Daniel Kämmerer; Elisa Neubauer; Stefan Schulz; Ingrid Simonitsch-Klupp; Barbara Kiesewetter; Markus Raderer; Amelie Lupp
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.